KPRX Kiora Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 7, 2026
$2,56
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,7752 haftanın en düşüğü
$2,9552 haftanın en yükseği
Piyasa Değeri (MRQ)
$11M
P/E
-1.0
Hisse Başına Kâr
$-2.64
Gelir
$0
rozetleriniz
52 Haftlık Aralık
$2–$3
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$12
P/E
-1.0
ROE
-56.6%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
KPRX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$2.56
Piyasa Değeri (MRQ)
$11M
P/E
-1.0
Hisse Başına Kâr
$-2.64
Gelir
$0
ROE
-56.6%
52 Haftlık Aralık
$2–$3
KPRX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 11 Haziran 2024 | 1-for-9 | Ters |
| 27 Eylül 2022 | 1-for-40 | Ters |
| 30 Ağustos 2019 | 1-for-15 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$02016-12-31 → 2025-12-31
Hisse Başına Kâr$-2.642020-12-31 → 2025-12-31
Serbest Nakit Akışı$-10M2017-12-31 → 2025-12-31
Net kar marjı·2016-12-31 → 2024-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | KPRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -1.05Y ort. ≈-1.7 | ≈-1.7 | · | · | |
| F/D (MRQ) | 0.75Y ort. ≈96.8 | ≈96.8 | 2.1 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -1.35Y ort. ≈-161.5 | ≈-161.5 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -1.35Y ort. ≈-130.7 | ≈-130.7 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 0.85Y ort. ≈472.7 | ≈472.7 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | KPRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -35.7%5Y ort. ≈-49.3% | ≈-49.3% | -44.9% | En üst düzey | |
| ROE | -56.6%5Y ort. ≈-84.4% | ≈-84.4% | -57.2% | Aynı seviyede | |
| ROIC | -71.2%5Y ort. ≈-94.2% | ≈-94.2% | 348.2% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | KPRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 9.05Y ort. ≈4.4 | ≈4.4 | 3.1 | Güçlü likidite | |
| Cari Oran (MRQ) | 7.65Y ort. ≈3.6 | ≈3.6 | 3.0 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | KPRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.2 | ≈0.2 | 0.1 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 0.0 | · | 4.5 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$0.00 | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-2.0%
Sonraki Rapor
Kas 05, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 6, 2026 | $-0.34 | $-0.63 | 46.2% |
| 31 Mart 2026 | May 7, 2026 | $-0.58 | $-0.72 | 19.9% |
| 31 Aralık 2025 | $-1.59 | $-0.68 | -132.7% | |
| 30 Eylül 2025 | $0.01 | $-0.75 | 101.3% | |
| 30 Haziran 2025 | $-0.54 | $-0.62 | 12.5% | |
| 31 Mart 2025 | $-0.52 | $-0.68 | 23.9% | |
| 31 Aralık 2024 | $-1.04 | $-0.56 | -85.4% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $16M | $0 | · | $0 | $12.1K | $3M | $2M | $407.5K | $669.3K | $0 | |
| R&D Expense | $11M | $8M | $4M | $3M | $5M | $4M | $5M | $8M | $10M | $8M | $3M | |
| SG&A Expense | $6M | $6M | $5M | $8M | $5M | $5M | $4M | $4M | $5M | $6M | $4M | |
| Operating Expenses | $13M | $12M | $13M | $12M | $14M | $7M | $10M | $12M | $15M | $14M | $7M | |
| Operating Income | $-13M | $5M | $-13M | $-12M | $-14M | $-7M | · | $-11M | · | · | · | |
| Interest Expense | · | · | $11.1K | $8.6K | $6.9K | $4.2K | $325 | $1.0K | $1.2K | $275 | $2M | |
| Interest Income | $894.0K | $1M | $174.0K | $56.9K | $1.1K | $23.3K | $108.1K | $120.4K | $564 | $3.7K | $947 | |
| Other Non-op | $-160.3K | $26.1K | $28.8K | $-14.5K | $272.5K | $19.2K | $107.7K | $119.3K | $-651 | $3.4K | $10 | |
| Pretax Income | $-12M | $6M | $-12M | $-14M | $-14M | $-7M | $-7M | $-11M | $-15M | $-13M | $-8M | |
| Income Tax | $-1M | $2M | $90.3K | $-113.0K | $-192.6K | $12.1K | $95.4K | $86.0K | $-1M | $0 | · | |
| Net Income | $-11M | $4M | $-13M | $-14M | $-14M | $-7M | $-7M | $-11M | $-13M | $-13M | $-8M | |
| EPS (Basic) | $-2.60 | $0.93 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | · | · | · | · | · | |
| EPS (Diluted) | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | · | · | · | · | · | |
| Shares (Basic) | 4,166,692 | 3,872,644 | 538,007 | 732,303 | 241,099 | 4,591,491 | · | · | · | · | · | |
| Shares (Diluted) | 4,103,873 | 4,125,075 | 538,007 | 732,303 | 241,099 | 4,591,491 | · | · | · | · | · | |
| EBITDA | $-13M | $5M | $-13M | $-12M | $-14M | $33.4K | $51.7K | $-11M | $19.3K | $5.2K | $1.3K |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $4M | $2M | $6M | $8M | $1M | $4M | $8M | $8M | $4M | $8M | |
| Short-term Investments | $8M | $23M | $0 | · | · | · | · | · | · | · | · | |
| Receivables | $2M | $601.2K | $0 | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $2M | $233.4K | $343.1K | $606.5K | $449.6K | $458.8K | $455.8K | $629.6K | $465.0K | $122.4K | |
| Current Assets | $22M | $30M | $5M | $8M | $9M | $2M | $4M | $8M | $8M | $4M | $9M | |
| PP&E (Net) | $91.7K | $5.2K | $8.1K | $55.2K | $74.0K | $30.6K | $16.8K | $43.5K | $55.8K | $38.0K | $0 | |
| PP&E (Gross) | $117.6K | $6.3K | $14.4K | $172.5K | $187.1K | $123.5K | $99.6K | $99.6K | $79.6K | $42.6K | $268.1K | |
| Accum. Depreciation | $25.9K | $1.0K | $6.3K | $117.3K | $113.1K | $93.0K | $82.7K | $56.1K | $23.8K | $4.5K | $268.1K | |
| Goodwill | · | · | · | $0 | $0 | $4M | $2M | $2M | $2M | · | · | |
| Intangibles | $2M | $7M | $9M | $11M | $11M | $10M | $4M | $4M | $4M | · | · | |
| Other Non-current Assets | $59.7K | $24.9K | $40.8K | $33.0K | $43.0K | $57.1K | $69.4K | $31.7K | $307.1K | $55.3K | $38.6K | |
| Total Assets | $24M | $36M | $14M | $19M | $20M | $15M | $10M | $14M | $14M | $10M | $10M | |
| Accounts Payable | $1M | $415.6K | $206.3K | $1M | $160.6K | $434.8K | $210.3K | $63.7K | $706.1K | $1M | $417.7K | |
| Accrued Liabilities | $2M | $5M | $1M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | $212.3K | · | · | · | · | · | |
| Current Liabilities | $4M | $6M | $2M | $3M | $2M | $2M | $1M | $4M | $15M | $7M | $3M | |
| Capital Leases | $203.8K | $33.8K | $59.8K | $0 | $90.6K | $35.6K | $0 | $0 | $4.9K | $16.1K | $0 | |
| Deferred Tax | $102.2K | $490.7K | $779.4K | $689.1K | $802.1K | $728.9K | $365.4K | $270.0K | $183.9K | $2M | $0 | |
| Total Liabilities | $8M | $11M | $8M | $7M | $6M | $6M | $3M | $5M | $16M | $10M | $3M | |
| Total Debt | · | · | · | · | · | $278.2K | · | · | · | · | · | |
| Common Stock | $275.3K | $267.7K | $77.1K | $18.0K | $3.2K | $55.6K | $40.8K | $30.4K | $172.6K | $101.3K | $76.6K | |
| Paid-in Capital | $170M | $169M | $153M | $146M | $136M | $117M | $107M | $102M | $90M | $78M | $71M | |
| Retained Earnings | $-154M | $-143M | $-147M | $-134M | $-121M | $-107M | $-100M | $-93M | $-92M | $-79M | $-65M | |
| AOCI | $-246.1K | $-282.2K | $-182.8K | $-182.7K | $-86.4K | $-802 | $139.5K | $134.3K | $127.5K | $120.2K | $114.8K | |
| Stockholders' Equity | $16M | $26M | $6M | $11M | $15M | $10M | $7M | $9M | $-2M | $-329.4K | $6M | |
| Liabilities + Equity | $24M | $36M | $14M | $19M | $20M | $15M | $10M | $14M | $14M | $10M | $10M | |
| Shares Outstanding | 3,761,739 | 3,000,788 | 856,182 | 1,796,472 | 316,599 | 5,556,394 | 4,077,755 | 3,038,592 | 17,257,255 | 10,130,883 | 7,657,287 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24.8K | $19.2K | $51.8K | $41.6K | $45.3K | $33.4K | $51.7K | $38.5K | $19.3K | $5.2K | $1.3K | |
| Stock-based Comp | $900.2K | $656.6K | $754.9K | $462.4K | $842.5K | $723.9K | $852.2K | $875.3K | $870.3K | $511.0K | $1M | |
| Deferred Tax | · | · | $90.3K | $-113.0K | $-192.6K | $-12.1K | $-95.4K | $-86.0K | $1M | $0 | · | |
| Amort. of Intangibles | $0 | $15.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $6.2K | $0 | · | · | |
| Other Non-cash | $-51.1K | $4M | $2M | $3M | $2M | $29.6K | $-2M | $-860.8K | $7M | $4M | $3M | |
| Operating Cash Flow | $-10M | $9M | $-10M | $-10M | $-11M | $-7M | $-8M | $-11M | $-6M | $-8M | $-4M | |
| CapEx | $110.8K | $6.3K | $0 | $0 | $63.9K | $20.1K | $0 | $20.0K | $37.0K | $0 | · | |
| Investing Cash Flow | $14M | $-23M | $0 | $6.4K | $-157.0K | $-244.4K | $0 | $-270.0K | $-37.0K | $174.7K | · | |
| Debt Issued | · | · | · | · | $0 | $278.2K | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | · | $0 | $278.2K | · | · | · | · | · | |
| Stock Issued | · | · | · | $5M | $18M | $5M | $2M | $10M | $11M | $4M | $14M | |
| Net Stock Activity | · | · | · | $5M | $19M | $5M | $2M | $10M | $12M | $4M | · | |
| Financing Cash Flow | $265.7K | $15M | $6M | $9M | $18M | $5M | $4M | $11M | $11M | $3M | · | |
| Net Change in Cash | $5M | $1M | $-4M | $-2M | $7M | $-3M | $-4M | $198.2K | $4M | $-5M | $8M | |
| Taxes Paid | $2M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-10M | $9M | · | $-10M | $-11M | $-7M | · | $-11M | $-7M | · | · | |
| Levered FCF | · | · | · | $-10M | $-11M | $-7M | · | $-11M | $-7M | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 28.1% | · | · | · | · | · | -656.2% | · | · | · | |
| Net Margin | · | 22.4% | · | · | · | -67102.9% | -264.2% | -654.2% | -3243.5% | -1993.8% | · | |
| Pretax Margin | · | 35.3% | · | · | · | -67002.9% | -260.7% | -649.0% | -3572.8% | -1993.8% | · | |
| EBITDA Margin | · | 28.3% | · | · | · | 277.0% | 1.9% | -653.9% | 4.7% | 0.77% | · | |
| ROA | -35.7% | 14.3% | -77.3% | -70.0% | -77.7% | -64.0% | -58.2% | -75.6% | -110.0% | -138.7% | -153.7% | |
| ROE | -56.6% | 12.9% | -176.1% | -123.9% | -78.5% | -124.9% | -119.9% | -107.9% | 1171.6% | -463.5% | 41.2% | |
| ROIC | -71.2% | 11.1% | -207.5% | -107.0% | -96.3% | · | · | -122.3% | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 4.9 | 2.9 | 2.3 | 5.6 | 1.0 | 3.1 | 2.2 | 0.6 | 0.6 | 2.8 | |
| Quick Ratio | 5.1 | 4.6 | 1.5 | 1.8 | 4.9 | 0.7 | 2.7 | 2.1 | 0.5 | 0.5 | 2.5 | |
| Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | -1130.7 | -1431.5 | -2077.9 | · | · | -10427.6 | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.6 | · | · | 0.0 | 0.0 | 0.2 | 0.1 | 0.0 | 0.1 | · | |
| Receivables Turnover | 0.0 | 53.3 | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.29 | $8.58 | $0.79 | $6.35 | $1.15 | $1.26 | $1.62 | $0.20 | $-0.11 | $-0.03 | $0.79 | |
| Revenue / Share | $0.00 | $3.88 | · | · | $0.00 | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.43 | $2.07 | $-1.97 | $-14.24 | $-1.11 | · | · | · | · | · | · | |
| Cash / Share | $2.31 | $1.26 | $0.32 | $3.32 | $0.62 | $0.21 | $0.93 | $0.18 | $0.45 | $0.36 | $1.10 | |
| EPS (TTM) | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $16M | $0 | $0 | $0 | $12.1K | $3M | $2M | $407.5K | $669.3K | $0 | |
| Net Income TTM | $-11M | $4M | $-13M | $-14M | $-14M | $-7M | $-7M | $-11M | $-13M | $-13M | $-8M | |
| Market Cap | $7M | $10M | $36M | $55M | $6.88B | $9.86B | $14.71B | $109.97B | $99.71B | $89.17B | $113.30B | |
| Enterprise Value | · | · | · | · | · | $9.86B | · | · | · | · | · | |
| P/E | -0.7 | 3.8 | -0.2 | -1.7 | -9.5 | -1191.1 | · | · | · | · | · | |
| P/S | · | 0.6 | · | · | · | 817770.0 | 5476.3 | 66544.7 | 244682.2 | 133239.9 | · | |
| P/B | 0.5 | 0.4 | 5.9 | 4.9 | 472.2 | 1408.9 | 2221.1 | 12305.6 | -51747.0 | -270693.2 | 18613.7 | |
| P / Tangible Book | 0.5 | 0.5 | · | 83.5 | 1806.4 | · | · | · | · | · | · | |
| P / Cash Flow | -0.7 | 1.2 | -3.8 | -5.3 | -644.9 | -1347.7 | -1804.0 | -10140.3 | -15415.0 | -10599.1 | -25407.7 | |
| P / FCF | -0.7 | 1.2 | · | -5.3 | -641.0 | -1344.0 | · | -10121.6 | -15327.3 | · | · | |
| EV / EBITDA | · | · | · | · | · | 295235.8 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -1343.9 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | 817694.7 | · | · | · | · | · | |
| Earnings Yield | -134.0% | 26.4% | -516.2% | -60.1% | -10.5% | -0.08% | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $20.0K | $16M | $0 | $0 | $0 | $0 | · | · | |
| R&D Expense | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $438.3K | $841.6K | $1M | |
| SG&A Expense | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $880.5K | $1M | $1M | $1M | $3M | $2M | |
| Operating Expenses | $2M | $3M | $7M | $794.4K | $2M | $2M | $3M | $4M | $3M | $3M | $2M | $6M | $3M | $2M | $3M | $4M | |
| Operating Income | $-2M | $-3M | $-7M | $-794.4K | $-2M | $-2M | $-3M | $-4M | $-3M | $13M | $-2M | $-6M | $-3M | $-2M | $-3M | $-4M | |
| Interest Income | · | · | · | · | $225.2K | $277.3K | · | · | $342.1K | $223.2K | · | · | · | · | · | · | |
| Other Non-op | $-11.5K | $-47.1K | $-26.8K | $-23.7K | $-93.6K | $-16.3K | $96.8K | $-59.9K | $-18.9K | $8.1K | $-65.7K | $105.7K | $-25.9K | $14.7K | $-15.4K | $937 | |
| Pretax Income | $-2M | $-2M | $-7M | $-616.3K | $-2M | $-2M | $-2M | $-3M | $-2M | $13M | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $-650.0K | $-643.1K | $-112.1K | $123.0K | $2M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-2M | $-2M | $-7M | $26.8K | $-2M | $-2M | $-4M | $-3M | $-2M | $13M | $-2M | $-6M | $-3M | $-2M | $-2M | $-5M | |
| EPS (Basic) | $-0.34 | $-0.58 | $-1.55 | $0.01 | $-0.54 | $-0.52 | $-2.40 | $-0.81 | $-0.53 | $4.67 | $-8.80 | $-7.30 | $-7.15 | $-1.00 | $-1.07 | $-6.03 | |
| EPS (Diluted) | $-0.34 | $-0.58 | $-1.59 | $0.01 | $-0.54 | $-0.52 | $-1.25 | $-0.81 | $-0.53 | $3.46 | $-8.80 | $-7.30 | $-7.15 | $-1.00 | $-1.07 | $-6.03 | |
| Shares (Basic) | 6,177,679 | 4,174,802 | · | 4,289,853 | 3,989,042 | 4,217,007 | · | 4,214,950 | 4,170,627 | 2,881,796 | · | 789,656 | 365,530 | 1,863,466 | · | 848,534 | |
| Shares (Diluted) | 6,177,679 | 4,174,802 | · | 4,361,740 | 3,989,042 | 4,217,007 | · | 4,214,950 | 4,170,627 | 3,891,722 | · | 789,656 | 365,530 | 1,863,466 | · | 848,534 | |
| EBITDA | $-2M | $-2M | · | $-794.4K | $-2M | $-2M | · | $-4M | $-3M | $13M | · | $-6M | $-3M | $-2M | · | $-4M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $11M | $9M | $6M | $1M | $4M | $4M | $6M | $7M | $31M | $2M | $5M | $8M | $3M | $6M | $5M | |
| Short-term Investments | $10M | $3M | $8M | $14M | $20M | $20M | $23M | $23M | $21M | · | $0 | · | · | · | · | · | |
| Receivables | $1M | $2M | $2M | $1M | $2M | $1M | $601.2K | $2M | $1M | $189.9K | $0 | · | · | · | · | · | |
| Prepaid Expense | $1M | $1M | $1M | $650.4K | $957.1K | $941.5K | $2M | $470.4K | $339.6K | $206.7K | $233.4K | $239.4K | $266.5K | $488.9K | $343.1K | $260.0K | |
| Current Assets | $21M | $19M | $22M | $23M | $25M | $27M | $30M | $32M | $32M | $33M | $5M | $7M | $9M | $6M | $8M | $7M | |
| PP&E (Net) | $99.6K | $86.8K | $91.7K | $101.8K | $106.8K | $5.0K | $5.2K | $62.6K | $63.5K | $12.9K | $8.1K | $38.6K | $44.9K | $51.3K | $55.2K | $59.2K | |
| PP&E (Gross) | · | · | $117.6K | · | · | · | $6.3K | · | · | · | $14.4K | · | · | · | $172.5K | · | |
| Accum. Depreciation | · | · | $25.9K | · | · | · | $1.0K | · | · | · | $6.3K | · | · | · | $117.3K | · | |
| Intangibles | $2M | $2M | $2M | $7M | $7M | $7M | $7M | $7M | $9M | $9M | $9M | $9M | $11M | $11M | $11M | $11M | |
| Other Non-current Assets | $85.4K | $88.2K | $59.7K | $58.1K | $61.0K | $64.3K | $24.9K | $29.9K | $32.1K | $39.4K | $40.8K | $32.0K | $32.4K | $32.7K | $33.0K | $33.0K | |
| Total Assets | $24M | $21M | $24M | $30M | $32M | $34M | $36M | $39M | $41M | $42M | $14M | $16M | $20M | $17M | $19M | $18M | |
| Accounts Payable | $216.5K | $594.9K | $1M | $241.5K | $282.5K | $942.5K | $415.6K | $660.4K | $268.6K | $323.1K | $206.3K | $125.4K | $131.3K | $587.5K | $1M | $749.2K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | |
| Current Liabilities | $2M | $3M | $4M | $3M | $3M | $5M | $6M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Capital Leases | $160.6K | $195.4K | $203.8K | $248.2K | $287.1K | $87.5K | $33.8K | $39.2K | $40.2K | $46.4K | $59.8K | $0 | $0 | $0 | $0 | $4.8K | |
| Deferred Tax | $102.2K | $102.2K | $102.2K | $490.7K | $490.7K | $490.7K | $490.7K | $779.4K | $779.4K | $779.4K | $779.4K | $689.1K | $689.1K | $689.1K | $689.1K | $802.1K | |
| Total Liabilities | $7M | $7M | $8M | $7M | $10M | $10M | $11M | $8M | $8M | $8M | $8M | $8M | $6M | $6M | $7M | $7M | |
| Common Stock | $281.9K | $277.6K | $275.3K | $272.0K | $272.0K | $267.7K | $267.7K | $267.7K | $267.4K | $262.6K | $77.1K | $76.9K | $69.1K | $19.2K | $18.0K | $10.8K | |
| Paid-in Capital | $176M | $171M | $170M | $170M | $170M | $169M | $169M | $169M | $169M | $168M | $153M | $153M | $153M | $147M | $146M | $143M | |
| Retained Earnings | $-159M | $-157M | $-154M | $-148M | $-148M | $-146M | $-143M | $-139M | $-136M | $-134M | $-147M | $-145M | $-139M | $-136M | $-134M | $-132M | |
| AOCI | $-255.8K | $-228.8K | $-246.1K | $-243.7K | $-245.8K | $-297.2K | $-282.2K | $-75.2K | $-245.7K | $-264.4K | $-182.8K | $-266.2K | $-225.9K | $-215.4K | $-182.7K | $-263.4K | |
| Stockholders' Equity | $17M | $14M | $16M | $22M | $22M | $24M | $26M | $30M | $33M | $35M | $6M | $8M | $14M | $10M | $11M | $11M | |
| Liabilities + Equity | $24M | $21M | $24M | $30M | $32M | $34M | $36M | $39M | $41M | $42M | $14M | $16M | $20M | $17M | $19M | $18M | |
| Shares Outstanding | 4,427,167 | 3,993,469 | 3,761,739 | 3,433,491 | 3,433,491 | 3,000,788 | 3,000,788 | 3,000,788 | 2,970,545 | 26,256,197 | 856,182 | 7,689,240 | 6,910,720 | 1,919,270 | 1,796,472 | 1,079,045 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $10.7K | $10.6K | $10.5K | $10.6K | $3.4K | $318 | $5.9K | $2.1K | $6.3K | $4.9K | $7.9K | $11.3K | $22.5K | $10.1K | $10.3K | $10.3K | |
| Stock-based Comp | $109.3K | $209.5K | $234.4K | $254.4K | $262.8K | $148.6K | $160.2K | $171.2K | $149.8K | $175.4K | $182.3K | $264.9K | $171.8K | $135.9K | $45.1K | $130.2K | |
| Other Non-cash | · | $-963.4K | · | · | · | $-660.2K | · | · | · | $-8.7K | · | · | · | $-1M | · | · | |
| Operating Cash Flow | $-2M | $-3M | $-2M | $-1M | $-4M | $-3M | $-2M | $920.1K | $-4M | $14M | $-3M | $-3M | $-1M | $-3M | $-2M | $-3M | |
| CapEx | $23.5K | $5.0K | $78.2K | $431 | $32.2K | $0 | $-45.0K | $0 | · | · | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | $-7M | $5M | $5M | $6M | $664.2K | $3M | $482.7K | $-2M | $-21M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $343.4K | $99.0K | · | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $99.0K | · | · | |
| Financing Cash Flow | $5M | $-842 | $296 | $0 | $265.4K | $0 | $0 | $0 | $250.5K | $15M | $-486.4K | $0 | $6M | $513.2K | $3M | $5M | |
| Net Change in Cash | $-4M | $2M | $3M | $4M | $-3M | $-21.3K | $-2M | $-938.0K | $-25M | $29M | $-3M | $-3M | $5M | $-3M | $1M | $2M | |
| Free Cash Flow | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -12724.4% | 82.6% | · | -11858.0% | -5839.8% | -5727.4% | · | -47106.4% | |
| Net Margin | · | · | · | · | · | · | · | · | -11108.2% | 84.1% | · | -11546.2% | -5797.3% | -5583.6% | · | -65123.2% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -12724.4% | 82.7% | · | -11858.0% | -5839.8% | -5697.3% | · | -47106.4% | |
| ROA | -7.5% | -8.8% | · | 0.08% | -5.9% | -5.7% | · | -12.6% | -7.3% | 45.6% | · | -34.4% | -14.8% | -10.9% | · | -23.7% | |
| ROE | -10.7% | -12.8% | · | 0.10% | -7.8% | -7.5% | · | -17.9% | -9.5% | 59.7% | · | -61.9% | -23.3% | -17.4% | · | -36.7% | |
| ROIC | -13.1% | -18.0% | · | 0.15% | -10.3% | -10.4% | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | 6.7 | · | 8.8 | 7.8 | 5.1 | · | 9.0 | 19.2 | 21.0 | · | 3.3 | 4.8 | 2.6 | · | 2.2 | |
| Quick Ratio | 7.6 | 5.5 | · | 8.0 | 7.2 | 4.8 | · | 8.7 | 17.6 | 19.8 | · | 2.6 | 4.2 | 1.6 | · | 1.6 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.5 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 168.5 | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.81 | $3.49 | · | $6.53 | $6.44 | $7.90 | · | $10.01 | $11.14 | $1.33 | · | $1.05 | $1.97 | $5.29 | · | $9.75 | |
| Revenue / Share | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.46 | · | $0.01 | $0.01 | $0.02 | · | $0.01 | |
| Cash Flow / Share | · | $-0.76 | · | · | · | $-0.64 | · | · | · | $0.39 | · | · | · | $-1.65 | · | · | |
| Cash / Share | $1.60 | $2.74 | · | $1.60 | $0.30 | $1.26 | · | $1.88 | $2.21 | $1.19 | · | $0.70 | $1.15 | $1.79 | · | $4.45 | |
| EPS (TTM) | $-2.50 | $-2.70 | · | $-2.30 | $-3.12 | $-3.11 | · | $-6.68 | $-13.17 | $-19.79 | · | $-16.52 | $-15.25 | $-8.28 | · | $-62.65 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $20.0K | · | $16M | $16M | $16M | · | · | · | · | · | $12.1K | |
| Net Income TTM | $-11M | $-11M | · | $-9M | $-12M | $-12M | · | $6M | $3M | $3M | · | $-13M | $-12M | $-12M | · | $-17M | |
| Market Cap | $12M | $8M | · | $10M | $10M | $9M | · | $11M | $12M | $167M | · | $39M | $40M | $58M | · | $60M | |
| P/E | -1.1 | -0.7 | · | -1.2 | -0.9 | -1.0 | · | -0.5 | -0.3 | -0.3 | · | -0.3 | -0.4 | -3.6 | · | -0.9 | |
| P/S | · | · | · | · | · | 451.6 | · | 0.7 | 0.8 | 10.4 | · | · | · | · | · | 4952.7 | |
| P/B | 0.7 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 4.8 | · | 4.9 | 2.9 | 5.7 | · | 5.7 | |
| P / Tangible Book | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.5 | 6.4 | · | · | 13.7 | · | · | · | |
| P / Cash Flow | · | -2.4 | · | · | · | -3.3 | · | · | · | 12.2 | · | · | · | -18.8 | · | · | |
| Earnings Yield | -95.1% | -139.9% | · | -82.7% | -108.3% | -103.3% | · | -182.5% | -313.6% | -311.5% | · | -323.2% | -263.5% | -27.5% | · | -113.2% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $0 | $16M | $0 | · | $0 |
| Faaliyet Kâr Marjı % | · | 28.1% | · | · | · |
| Net Gelir | $-11M | $4M | $-13M | $-14M | $-14M |
| Seyreltilmiş Hisse Başı Kâr | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 6.0 | 4.9 | 2.9 | 2.3 | 5.6 |
| Cari Oran | 5.1 | 4.6 | 1.5 | 1.8 | 4.9 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-10M | $9M | · | $-10M | $-11M |
Kurumsal Sahipler (13F) 23 dosya · $2.8M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
23
Tutulan Değer
$2.8M
Yeni pozisyonlar
10
Çıkan pozisyonlar
6
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 10 (+3 önceki Ç'ye göre) | 6 (0 önceki Ç'ye göre) | 3 (-1 önceki Ç'ye göre) | 2 (+1 önceki Ç'ye göre) | +766K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | $1.153.179 | 438.471 | 40,91% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $441.685 | 167.941 | 15,67% | Hisse senetleri |
| CITADEL ADVISORS LLC | $305.109 | 116.011 | 10,82% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $233.523 | 88.792 | 8,28% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $195.151 | 74.202 | 6,92% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $78.437 | 29.824 | 2,78% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $70.264 | 26.717 | 2,49% | Hisse senetleri |
| VANGUARD GROUP INC | $65.189 | 33.091 | 2,31% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $52.234 | 19.861 | 1,85% | Hisse senetleri |
| Scientech Research LLC | $49.302 | 18.746 | 1,75% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $34.269 | 13.030 | 1,22% | Hisse senetleri |
| LPL Financial LLC | $32.875 | 12.500 | 1,17% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $31.923 | 12.138 | 1,13% | Hisse senetleri |
| NORTHERN TRUST CORP | $30.947 | 11.767 | 1,10% | Hisse senetleri |
| JANE STREET GROUP, LLC | $27.918 | 10.615 | 0,99% | Hisse senetleri |
| UBS Group AG | $5.157 | 1.961 | 0,18% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $4.768 | 1.813 | 0,17% | Hisse senetleri |
| MORGAN STANLEY | $3.703 | 1.408 | 0,13% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $2.201 | 837 | 0,08% | Hisse senetleri |
| SBI Securities Co., Ltd. | $673 | 256 | 0,02% | Hisse senetleri |
| HRT FINANCIAL LP | $154 | 58.612 | 0,01% | Hisse senetleri |
| BlackRock, Inc. | $153 | 58 | 0,01% | Hisse senetleri |
| Activest Wealth Management | $5 | 2 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Armistice Capital, LLC, Steven Boyd ×10 başvurular | 03 Ağustos 2021 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| IPSA (formerly Innoven Partenaires S.A.), FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Capital 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI La Banque Postale Innovation 1, Jean-Michel Paulhac ×3 başvurular | 17 Ocak 2018 | · | İlk başvuru | Pasif yatırım | SEC |
| Innoven Partenaires S.A. (IPSA), Innoven 2002 FCPI N°6, Innoven 2003 FCPI N°7, FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Europe 3, FCPI Innoven Capital, FCPI Innoven Capital 2, FCPI Poste Innovation, FCPI Poste Innovation 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI Poste Innovation 9, FCPI La Banque Postale Innovation 1, Jean-Michel Paulhac, Thomas Balland ×2 başvurular | 16 Haziran 2017 | · | İlk başvuru | Pasif yatırım | SEC |
| FCPR Ventech A, FCPR Ventech B, FCPR Ventech Coinvest, FCPR Ventech Capital II, Alain Caffi, Jean Bourcereau ×2 başvurular | 16 Haziran 2017 | · | İlk başvuru | Pasif yatırım | SEC |
| Stephen From | 04 Mart 2015 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 29 içeriden öğrenenler · 9 yöneticiler · 13 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Brian M. Strem | President and CEO | 01 Temmuz 2026 F | 58.823 | 0 | 0 | $0 |
| Melissa Tosca | CFO | 01 Temmuz 2026 F | 26.064 | 0 | 0 | $0 |
| Sarah Romano | Chief Financial Officer | 10 Şubat 2022 F | 22.746 | 0 | 0 | $0 |
| Ryan Randall Brenneman | Chief Financial Officer | 18 Temmuz 2016 A | · | 0 | 0 | $0 |
| Stephen From | Executive Chairman | 05 Ocak 2022 F | 67.693 | 0 | 0 | $0 |
| Brenda Mann | VP of Research & Development | 02 Kasım 2021 F | 15.136 | 0 | 0 | $0 |
| MANZO MICHAEL P. | VP of Engineering | 03 Ağustos 2021 F | 15.378 | 0 | 0 | $0 |
| Barbara Wirostko | Chief Medical Officer | 06 Ağustos 2019 F | 403.893 | 0 | 0 | $0 |
| Michael Garanzini | Chief Commercial Officer | 10 Temmuz 2018 A | 196.250 | 0 | 0 | $0 |
| Erin Parsons | Yönetim kurulu üyesi | 10 Haziran 2026 A | 5.260 | 0 | 0 | $0 |
| Carmine N. Stengone | Yönetim kurulu üyesi | 10 Haziran 2026 A | 1.250 | 0 | 0 | $0 |
| Aron Shapiro | Yönetim kurulu üyesi | 10 Haziran 2026 A | 3.000 | 0 | 0 | $0 |
| David Hollander | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Lisa Walters-Hoffert | Yönetim kurulu üyesi | 10 Haziran 2026 A | 1.250 | 0 | 0 | $0 |
| Praveen Tyle | Yönetim kurulu üyesi | 10 Haziran 2026 A | 5.014 | 0 | 0 | $0 |
| Morton Goldberg | Yönetim kurulu üyesi | 01 Şubat 2021 A | 0 | 0 | 0 | $0 |
| Thomas Hancock | Yönetim kurulu üyesi | 01 Şubat 2021 A | 13.487 | 0 | 0 | $0 |
| Peter Greenleaf | Yönetim kurulu üyesi | 01 Şubat 2019 A | · | 0 | 0 | $0 |
| Thomas Balland | Yönetim kurulu üyesi | 21 Haziran 2017 A | 10.422 | 0 | 0 | $0 |
| Mounia Chaoui | Yönetim kurulu üyesi | 29 Mart 2016 A | 10.422 | 0 | 0 | $0 |
| Ventech Capital II | 10% sahip | 13 Mart 2017 S | 1.431.814 | 0 | 0 | $0 |
| NATIXIS PRIVATE EQUITY | 10% sahip | 19 Şubat 2015 C | 674.205 | 0 | 0 | $0 |
| IPSA (INNOVEN PARTENAIRES S.A.) | 10% sahip | 19 Şubat 2015 C | 1.460.479 | 0 | 0 | $0 |
| Keith J. Lane | · | 17 Eylül 2026 A | · | 0 | 0 | $0 |
| Eric Joseph Daniels | · | 01 Nisan 2026 F | 31.741 | 0 | 0 | $0 |
| Kenneth L Gayron | · | 29 Eylül 2023 A | · | 0 | 0 | $0 |
| Paul G Chaney | · | 03 Mart 2023 A | 91.229 | 0 | 0 | $0 |
| Franz Obermayr | · | 01 Şubat 2021 A | · | 0 | 0 | $0 |
| Bernard Malfroy-Camine | · | 01 Şubat 2021 A | 61.525 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 3 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
KPRX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
AL
Medyan hedef
$12.00
+368,7%
2 28,6%
Güçlü Al
4 57,1%
Al
1 14,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
1 analist · 2026-10-03Ortalama hedef $12.00 +368,7%
Düşük$12.00
Ortalama$12.00
Yüksek$12.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 7, 2026